In early 2026, the "Pharmaceutical Branch" of the "Animal Health Industry" has "Accelerated Drug Development" by using "AI Simulation" to replace "Traditional Animal Testing." These 2026 "In Silico Models" can predict how "New Drug Molecules" will interact with "Species-Specific Receptors" (such as Canine vs. Equine), significantly "Reducing the Failure Rate" of "Clinical Trials." In early...